Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $78.6300 (-0.96%) ($78.1400 - $80.1500) on Tue. Aug. 20, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.21% (three month average) | RSI | 59 | Latest Price | $78.6300(-0.96%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 2.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) XLC(33%) IBB(24%) IYT(24%) VFMO(24%) BOTZ(23%) | Factors Impacting SGEN price | SGEN will decline at least -1.605% in a week (0% probabilities). VIXM(-14%) VXX(-6%) TLT(-2%) IGOV(-1%) UUP(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.605% (StdDev 3.21%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
5 Day Moving Average | $78.18(0.58%) | 10 Day Moving Average | $77.52(1.43%) | 20 Day Moving Average | $76.18(3.22%) | To recent high | -1% | To recent low | 24.5% | Market Cap | $13.671b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |